Lactobacillus delbrueckii subsp. lactis CKDB001 Ameliorates Metabolic Complications in High-Fat Diet-Induced Obese Mice
2024

Probiotic Lactobacillus delbrueckii subsp. lactis CKDB001 Improves Metabolic Health in Obese Mice

Sample size: 48 publication 10 minutes Evidence: moderate

Author Information

Author(s): Jang Hyunsoo, Joung Hyunchae, Chu Jaeryang, Cho Minseo, Kim Yeon-Woo, Kim Kyung Hwan, Shin Chang Hun, Lee Jisu, Ha Jung-Heun

Primary Institution: Dankook University

Hypothesis

The study investigates the effects of Lactobacillus delbrueckii subsp. lactis CKDB001 on metabolic complications in high-fat diet-induced obese mice.

Conclusion

Lactobacillus delbrueckii subsp. lactis CKDB001 supplementation improved insulin sensitivity, reduced liver fat accumulation, and mitigated metabolic dysfunction in obese mice.

Supporting Evidence

  • LL supplementation reduced body weight and insulin levels in HFD-fed mice.
  • LL improved liver function markers and reduced hepatic triglyceride levels.
  • LL treatment enhanced AMPK phosphorylation, indicating improved energy metabolism.

Takeaway

This study shows that a probiotic called Lactobacillus can help mice lose weight and improve their health when they eat a lot of fat.

Methodology

Mice were divided into four groups and fed different diets for 24 weeks, followed by treatment with either the probiotic or a control.

Potential Biases

Potential funding bias as the research was supported by the National Research Foundation of Korea.

Limitations

The study's findings may not directly translate to humans due to differences in metabolism and gut microbiota.

Participant Demographics

C57BL/6J male mice, aged four weeks at the start of the study.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3390/nu16244260

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication